NationalICMR Distances Itself From BHU's 'Poorly Designed' Study On Covaxin Side EffectsBY Asmita Ravi Shankar
NationalAfter Covishield, Now Covaxin Hits Headlines Over 'Health Issues' In 30% Of Those JabbedBY Outlook News Desk
NationalBharat Biotech Highlights Covaxin's 'Safety First' Feature Amid AstraZeneca's Covishield Row Over Side EffectsBY Outlook News Desk
NationalSerum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For AdultsBY PTI
NationalCovovax Booster Dose For Covid-19, Its Efficacy Rate And How Does It Work? All You Need To KnowBY Outlook News Desk
NationalGovernment Not Liable For Vaccine-Related Deaths: Centre To Supreme CourtBY Outlook News Desk
NationalImmunity From Natural Covid Infection, Vaccines Not Absolute: Minister of State for HealthBY Outlook News Desk
NationalNTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 YearsBY Outlook News Desk
NationalCovaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows StudyBY Outlook News Desk
NationalCovaxin Booster Dose Enhances Vaccine Effectiveness Against Delta, Omicron Variants, Says ICMR StudyBY Outlook News Desk
NationalBiological E Seeks EUA For Corbevax As Booster In Adults Vaccinated With Covishield, CovaxinBY Outlook News Desk
NationalBharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEABY Outlook News Desk
NationalDCGI Grants EUA To Corbevax For Those Aged 5-12, Covaxin For 6-12 Age GroupBY Outlook News Desk
NationalCovid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: ReportsBY Outlook News Desk
NationalSII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price DifferenceBY Outlook News Desk
NationalCovaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: StudyBY Outlook News Desk
